Specgx Llc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MORPHINE SULFATE, with a corresponding US DMF Number 5857.
Remarkably, this DMF maintains an Active status since its submission on June 03, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 08, 2013, and payment made on November 27, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II